Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.

In this investigation, we studied the expression of inducible nitric oxide synthase (iNOS) and its association to apoptosis and angiogenesis in 43 in situ and 68 invasive breast carcinomas. Its expression was studied immunohistochemically using a polyclonal iNOS antibody, and the staining was evaluated both in tumor and stromal cells. Apoptosis was detected by 3' end labeling of fragmented DNA (terminal deoxynucleotidyl transferase-mediated nick end labeling method). Vascularization was detected immunohistochemically using an antibody to the FVIII-related antigen, and calculated microvessel densities were determined. In addition to strong iNOS expression in stromal cells, iNOS positivity was observed in tumor cells in 46.5% of in situ and 58.8% of invasive carcinomas. In invasive carcinomas, there were more cases with iNOS positivity both in tumor and stromal cells compared to in situ carcinomas (0.007). The proportion of cases with iNOS-positive tumor cells increased in in situ carcinomas from grade I to III (20.0%, 46.2%, and 73.3%). In invasive ductal carcinomas, there were more cases with iNOS-positive tumor cells than with in situ carcinomas (P = 0.04). Carcinomas with both iNOS-positive tumor and stromal cells had a higher apoptotic index (P = 0.02) and a higher calculated microvessel densities index (P = 0.02). A high number of iNOS-positive stromal cells associated with metastatic disease (P = 0.05). The results show that breast carcinoma cells, in addition to stromal cells, express iNOS and are capable of producing NO. Carcinomas with iNOS-positive tumor and stromal cells have a higher apoptotic indices and increased vascularization, suggesting that iNOS contributes to promotion of apoptosis and angiogenesis in breast carcinoma. The association of the number of iNOS-positive stromal cells with metastatic disease might be attributable to stimulation of angiogenesis, resulting in a higher vascular density and consequently a higher probability for tumor cells to invade.

[1]  P. Lala,et al.  Animal Model Nitric Oxide Synthase Inhibition by N G -Nitro- L Arginine Methyl Ester Inhibits Tumor-Induced Angiogenesis in Mammary Tumors , 1999 .

[2]  T. Billiar,et al.  Nitric‐oxide production by murine mammary adenocarcinoma cells promotes tumor‐cell invasiveness , 1999, International journal of cancer.

[3]  T. Morisaki,et al.  Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue , 1999, Journal of surgical oncology.

[4]  R. Weiss,et al.  Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. , 1999, The Journal of urology.

[5]  Y. Soini,et al.  Apoptosis during breast carcinoma progression. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  N. Ziats,et al.  Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. , 1999, American journal of physiology. Cell physiology.

[7]  Y. Soini,et al.  Histopathological evaluation of apoptosis in cancer. , 1998, The American journal of pathology.

[8]  Xing-li Wang,et al.  Nitric oxide induces and inhibits apoptosis through different pathways , 1998, FEBS letters.

[9]  B. Brüne,et al.  Nitric oxide and its role in apoptosis. , 1998, European journal of pharmacology.

[10]  U. Engelmann,et al.  Selective expression of inducible nitric oxide synthase in human prostate carcinoma , 1998, Cancer.

[11]  James B. Mitchell,et al.  The multifaceted roles of nitric oxide in cancer. , 1998, Carcinogenesis.

[12]  H. Majewski,et al.  17β-Estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS. , 1998, American journal of physiology. Heart and circulatory physiology.

[13]  Toshio Hayashi,et al.  Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. , 1998, Journal of cardiovascular pharmacology.

[14]  J. Martin,et al.  ZR-75-1 human breast cancer cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production. , 1998, Cancer letters.

[15]  C. Harris,et al.  Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. , 1998, Cancer research.

[16]  Y. Soini,et al.  The extent of apoptosis is inversely associated with bcl‐2 expression in premalignant and malignant breast lesions , 1997, Histopathology.

[17]  J. Stamler,et al.  Nitric Oxide Inhibits Fas-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[18]  A. Zeiher,et al.  Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. , 1997, Nitric oxide : biology and chemistry.

[19]  R. González-Sarmiento,et al.  Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  G. Kroemer,et al.  Nitric oxide induces apoptosis via triggering mitochondrial permeability transition , 1997, FEBS letters.

[21]  Kazuo Kyuma,et al.  Classification of Breast Tumors Using Neural Network , 1997 .

[22]  C. Harris,et al.  Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[24]  Simon C Watkins,et al.  Nitric Oxide Protects Cultured Rat Hepatocytes from Tumor Necrosis Factor-α-induced Apoptosis by Inducing Heat Shock Protein 70 Expression* , 1997, The Journal of Biological Chemistry.

[25]  Y. Soini,et al.  Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. , 1996, British Journal of Cancer.

[26]  S. Moochhala,et al.  Nitric oxide synthase activity and expression in human colorectal cancer. , 1996, Carcinogenesis.

[27]  S. Russell,et al.  Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages , 1996, Journal of leukocyte biology.

[28]  Y. Soini,et al.  Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. , 1995, Cancer research.

[29]  G. Karakiulakis,et al.  Inhibition of angiogenesis, tumour growth and metastasis by the NO‐releasing vasodilators, isosorbide mononitrate and dinitrate , 1995, British journal of pharmacology.

[30]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.

[31]  Keiichiro Suzuki,et al.  Apoptotic Cell Death Triggered by Nitric Oxide in Pancreatic β-Cells , 1995, Diabetes.

[32]  P Rhodes,et al.  Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Dubertret,et al.  The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine‐deprived human eosinophils , 1995, FEBS letters.

[34]  J. Stamler,et al.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation , 1994, Cell.

[35]  S Amerini,et al.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.

[36]  C. Nathan,et al.  Regulation of biosynthesis of nitric oxide. , 1994, The Journal of biological chemistry.

[37]  A. Koch,et al.  Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Peristeris,et al.  Evidence that nitric oxide is an endogenous antiangiogenic mediator , 1994, British journal of pharmacology.

[39]  Richard Graham Knowles,et al.  Nitric oxide synthase activity in human gynecological cancer. , 1994, Cancer research.

[40]  M. Maragoudakis,et al.  Nitric oxide is involved in the regulation of angiogenesis , 1993, British journal of pharmacology.

[41]  V. Souvannavong,et al.  Nitric oxide synthase induces macrophage death by apoptosis. , 1993, Biochemical and biophysical research communications.

[42]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[43]  J. Hendriks,et al.  Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.

[44]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[45]  H. Kaneto,et al.  Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. , 1995, Diabetes.

[46]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .